IRIS - Res&Arch Institutional Research Information System - Research & Archive

LISO, Arcangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.482
AS - Asia 1.944
EU - Europa 1.787
SA - Sud America 342
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 6.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.432
SG - Singapore 937
IE - Irlanda 299
UA - Ucraina 281
IT - Italia 277
BR - Brasile 269
RU - Federazione Russa 253
CN - Cina 238
HK - Hong Kong 212
SE - Svezia 186
VN - Vietnam 181
DE - Germania 126
FR - Francia 103
FI - Finlandia 96
KR - Corea 85
BD - Bangladesh 77
GB - Regno Unito 58
IN - India 47
AR - Argentina 30
TR - Turchia 26
IQ - Iraq 25
CA - Canada 21
CH - Svizzera 20
MX - Messico 18
ZA - Sudafrica 18
UZ - Uzbekistan 17
PL - Polonia 16
NL - Olanda 15
SA - Arabia Saudita 14
MA - Marocco 13
PK - Pakistan 13
AT - Austria 12
BE - Belgio 12
ID - Indonesia 10
PH - Filippine 10
CO - Colombia 9
EC - Ecuador 9
ES - Italia 9
VE - Venezuela 8
EU - Europa 7
PY - Paraguay 7
LB - Libano 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
GR - Grecia 5
JO - Giordania 5
JP - Giappone 5
EG - Egitto 4
NP - Nepal 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KG - Kirghizistan 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AO - Angola 1
AU - Australia 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
YT - Mayotte 1
Totale 6.619
Salva come PNG Salva come JPEG
Città #
Singapore 638
Chandler 311
Dublin 298
San Jose 291
Hong Kong 212
San Mateo 176
Ashburn 158
Jacksonville 146
Perugia 113
Santa Clara 108
Moscow 91
Boardman 89
Seoul 84
Dong Ket 80
Beijing 79
Medford 68
Princeton 66
Ann Arbor 65
Lauterbourg 64
Wilmington 58
Altamura 54
Andover 46
New York 43
Lawrence 42
Council Bluffs 32
Ho Chi Minh City 29
Los Angeles 29
Piscataway 29
Helsinki 27
Munich 24
Des Moines 20
Hanoi 20
São Paulo 18
Frankfurt am Main 15
Houston 14
Izmir 14
Woodbridge 14
Dallas 13
Brussels 12
Falls Church 12
London 12
Saint Petersburg 12
Norwalk 11
The Dalles 11
Belo Horizonte 10
Brooklyn 10
Johannesburg 10
Orem 10
San Paolo di Civitate 10
Rome 9
Shanghai 9
Tashkent 9
Turku 9
Haiphong 8
Manchester 8
San Francisco 8
Amsterdam 7
Baghdad 7
Chennai 7
Curitiba 7
Da Nang 7
Denver 7
Fairfield 7
Falkenstein 7
Coccaglio 6
Columbus 6
Mexico City 6
Phoenix 6
Rio de Janeiro 6
Riyadh 6
Asunción 5
Auburn Hills 5
Buenos Aires 5
Charlotte 5
Guangzhou 5
Montreal 5
Porto Alegre 5
Stockholm 5
Tunis 5
Uberlândia 5
Warsaw 5
Amman 4
Ankara 4
Atlanta 4
Bologna 4
Buffalo 4
Campinas 4
Casablanca 4
Dammam 4
Florence 4
Guayaquil 4
Hefei 4
Lausanne 4
Marrakesh 4
Milan 4
New Delhi 4
Nuremberg 4
Philadelphia 4
Secaucus 4
Tokyo 4
Totale 4.081
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 173
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 163
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 157
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 143
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 142
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 123
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 114
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 114
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 114
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 111
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 110
BRAF mutations in hairy-cell leukemia. 108
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 108
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 106
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 106
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 106
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 105
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 105
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 105
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 104
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 104
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 101
Targeted antibodies in the treatment of lymphomas. 98
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 98
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 98
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 97
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 96
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 95
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 95
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML 91
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 88
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 84
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. 84
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 84
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. 83
Seasonality of birth for skin melanoma deserves further investigation 81
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 80
High anti-PLAC1 antibody levels in idiopathic infertile patients with repeated unexplained implantation failure 80
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 78
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 77
The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress 76
Vaccine therapy of B cell malignancies: Different strategies for a novel approach 76
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 75
Selective silencing of the NPM1 mutant protein and apoptosis induction upon ATRA in vitro treatment of AML cells carrying NPM1 mutations. 74
Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice. 73
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. 72
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 72
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines 71
SELECTIVE SILENCING OF THE NPM1 MUTANT PROTEIN AND APOPTOSIS INDUCTION UPON ATRA IN VITRO TREATMENT OF AML CELLS CARRYING NPM1 MUTATIONS 71
From fever to immunity: A new role for IGFBP-6? 71
Seasonal Variation in Skin Cancer Diagnosis 69
Modulatory effects of mycobacterial heat-shock protein 70 in DNA vaccination against lymphoma 68
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 68
PLAC1 immunization does not induce infertility in mice 68
Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling 67
Minimally invasive surgical versus transcatheter aortic valve replacement: A multicenter study 64
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. 63
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 63
Seasonal variation in the month of birth in patients with skin cancer 63
null 62
Computational modeling of the immune response to tumor antigens. 60
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 57
EVIDENCE FOR CD34+HEMATOPOIETIC PROGENITOR CELL INVOLVEMENT IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION: IMPLICATIONS FOR THE CELL OF ORIGIN 57
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 55
Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae 55
Immunophenotypic and molecular features of ‘cuplike’ acute myeloid leukemias 55
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 55
CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS ARE INVOLVED IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION 51
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 50
Tumor Protein D52 (TPD52): A Novel B Cell/Plasma Cell Molecule Identified through a Proteomic Approach and Characterized by Unique Expression Pattern and Ca2+-Dependent Association with Annexin VI 46
Proteasome inhibitors as a possible therapy for SARS-CoV-2 42
Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes 41
Evidence for CD34+Hematopoietic Progenitor Cell Involvement in Acute Myeloid Leukemia with NPM1 Gene Mutation: Implications for the Cell of Origin 41
Multidrug-Resistant Bacteria Contaminating Plumbing Components and Sanitary Installations of Hospital Restrooms 40
IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression 37
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 37
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 36
Redox Biology and Insulin-like Growth Factor-Binding Protein-6: A Potential Relationship 31
Insulin Growth Factor Binding Protein-6 and the Liver 29
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 25
Activity of a foam in preventing rebound of vancomycin-resistant Enterococcus faecium-containing droplets generated from the toilet bowl 19
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 15
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL) 13
Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile PCOS women 13
USE OF ANTI-PLAC1 PROTEIN ANTIBODIES AS BIOMARKERS OF INFERTILITY, DIAGNOSTIC KIT FOR THE DETECTION OF THE IMMUNE RESPONSE AGAINST PLAC1 AND USE OF PLAC1 PROTEIN IN THERAPEUTIC AND CONTRACEPTIVE FIELDS 13
High anti PLAC 1 antibody levels in idiopathic infertile patients with repetaed unexplained implantation failure 13
Cohesin complex is a major player on the stage of leukemogenesis 12
Reduced percentage of postovulatory natural killer cells associated with impaired cytokines network in the secretory endometrium of infertile PCOS women 12
Donor selection for allogenic hemopoietic stem cell transplantation: Clinical and ethical considerations 10
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 10
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 10
Use of design of experiments to optimize the production of microbial probiotic biofilms 10
Preliminary evidence for high anti-PLAC1 antibody levels in infertile patients with repeated unexplained implantation failure 9
Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma 8
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 8
Hematopoietic Stem Cell Transplantation: A Bioethical Lens 8
Low dose intravenous bevacizumab for thetreatment of anaemia in hereditary haemorrhagic telangiectasia 7
Genome-wide computational approach for the prediction of duplications generating protein localization signals 6
DONOR SELECTION FOR ALLOGENIC HAEMOPOIETIC STEM CELL TRANSPLANTATION: CLINICAL AND ETHICAL CONSIDERATIONS 5
Totale 6.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022544 14 124 4 31 22 3 4 196 6 9 57 74
2022/2023989 71 177 10 76 72 100 0 46 384 9 32 12
2023/2024333 29 37 25 7 4 2 80 9 29 7 49 55
2024/20251.054 30 81 99 26 135 45 36 80 210 68 153 91
2025/20262.658 175 137 115 232 307 217 379 238 345 299 112 102
2026/202730 30 0 0 0 0 0 0 0 0 0 0 0
Totale 6.825